Personal profile
Area of Expertise
The three main areas of my research include:
1) Biomimetic drug delivery systems: bio-mimicking natures created by covering a polymeric nanoparticle with a cellular membrane extracted directly from cells;
2) Polymeric based nanoparticles: including the synthesis of targeted and non-targeted PLGA based nanoparticles. The targeting molecules such as peptides or antibodies may be attached using a linker which is either non-covalent or covalent to the polymeric or lipid surface using surface chemistry;
3) Curcumin Nano therapeutics: we have developed various nanoformulations using curcumin and are actively working to improve these nanoformulations to provide an effective way to deliver this drug.
Education/Academic qualification
BS in Chemical Engineering, Birsa Institute of Tech-Sindri
MTech in Chemical Engineering, IIT Bombay
PhD in Biochemical Engineering, IIT Delhi
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 14 Finished
-
NRMNet: A national resource for mentorship and networking to enhance diversity
Vishwanatha, J. (PI) & Ranjan, A. (CoI)
NIMHD: Natl Institute on Minority Health
1/07/19 → 30/06/24
Project: Research
-
NRMNet: A national resource for mentorship and networking to enhance diversity
Vishwanatha, J. (PI) & Ranjan, A. (CoI)
NIGMS: General Medical Sciences
1/07/19 → 30/06/24
Project: Research
-
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Core
Vishwanatha, J. (PI) & Ranjan, A. (CoI)
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
-
2/2 Langston University-UNTHSC Partnership for Cancer Research and Education Core
Vishwanatha, J. (PI) & Ranjan, A. (CoI)
NCI: National Cancer Institute
20/09/18 → 31/08/22
Project: Research
-
2/2 Langston University-UNTHSC
Basha, R. (PI) & Ranjan, A. (CoI)
NCI: National Cancer Institute
20/09/18 → 31/08/24
Project: Research
-
Establishment of human retinal microvascular endothelial cells with extended life-span
Kashyap, M. V., Ranjan, A. P., Shankardas, J. & Vishwanatha, J. K., 2013, In: In Vivo. 27, 6, p. 685-694 10 p.Research output: Contribution to journal › Article › peer-review
-
Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation
Ranjan, A. P., Mukerjee, A., Helson, L. & Vishwanatha, J. K., 14 Dec 2013, In: Journal of Nanobiotechnology. 11, 1, 40.Research output: Contribution to journal › Article › peer-review
-
Proof-of-concept studies with a computationally designed Mpro inhibitor as a synergistic combination regimen alternative to Paxlovid
Papini, C., Ullah, I., Ranjan, A. P., Zhang, S., Wu, Q., Spasov, K. A., Zhang, C., Mothes, W., Crawford, J. M., Lindenbach, B. D., Uchil, P. D., Kumar, P., Jorgensen, W. L. & Anderson, K. S., 23 Apr 2024, In: Proceedings of the National Academy of Sciences of the United States of America. 121, 17, e2320713121.Research output: Contribution to journal › Article › peer-review
-
Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
Gdowski, A. S., Ranjan, A., Sarker, M. R. & Vishwanatha, J. K., Sep 2017, In: Nanomedicine. 12, 17, p. 2083-2095 13 p.Research output: Contribution to journal › Article › peer-review
-
Differential distribution of intravenous curcumin formulations in the rat brain
Chiu, S. S., Lui, E., Majeed, M., Vishwanatha, J. K., Ranjan, A. P., Maitra, A., Pramanik, D., Smith, J. A. & Helson, L., Mar 2011, In: Anticancer Research. 31, 3, p. 907-911 5 p.Research output: Contribution to journal › Article › peer-review